Ignite Creation Date:
2025-12-26 @ 2:41 PM
Ignite Modification Date:
2025-12-26 @ 2:41 PM
Study NCT ID:
NCT00125606
Status:
TERMINATED
Last Update Posted:
2012-12-18
First Post:
2005-07-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase 3 Trial for AML Patients in CR2 Comparing 8Gy TBI /Fludarabine to Conditioning With TBI 12Gy/Cyclophosphamide
Sponsor:
University Hospital Muenster
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
AML_CR2_allo_HSCT
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None